These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28857962)

  • 1. Women's Awareness of and Responses to Messages About Breast Cancer Overdiagnosis and Overtreatment: Results From a 2016 National Survey.
    Nagler RH; Franklin Fowler E; Gollust SE
    Med Care; 2017 Oct; 55(10):879-885. PubMed ID: 28857962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of awareness of breast cancer overdiagnosis among women with screen-detected or incidentally found breast cancer: a qualitative interview study.
    Pickles K; Hersch J; Nickel B; Vaidya JS; McCaffery K; Barratt A
    BMJ Open; 2022 Jun; 12(6):e061211. PubMed ID: 35676016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eliciting women’s preferences for breast cancer screening].
    Sicsic J; Pelletier-Fleury N; Carretier J; Moumjid N
    Sante Publique; 2019; S2(HS2):7-17. PubMed ID: 32372583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. women's perceived importance of the harms and benefits of mammograms and associations with screening ambivalence: Results from a national survey.
    Qin X; Nagler RH; Fowler EF; Gollust SE
    Prev Med; 2019 Jun; 123():130-137. PubMed ID: 30890352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-review.
    Sohlberg EM; Metzner TJ; Leppert JT
    Eur Urol Focus; 2019 Nov; 5(6):943-945. PubMed ID: 30905599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care.
    Pillay J; Guitard S; Rahman S; Saba S; Rahman A; Bialy L; Gehring N; Tan M; Melton A; Hartling L
    Syst Rev; 2024 May; 13(1):140. PubMed ID: 38807191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overdiagnosis and Risks of Breast Cancer Screening.
    Neal CH; Helvie MA
    Radiol Clin North Am; 2021 Jan; 59(1):19-27. PubMed ID: 33222997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's Acceptance of Overdetection in Breast Cancer Screening: Can We Assess Harm-Benefit Tradeoffs?
    Stiggelbout A; Copp T; Jacklyn G; Jansen J; Liefers GJ; McCaffery K; Hersch J
    Med Decis Making; 2020 Jan; 40(1):42-51. PubMed ID: 31722605
    [No Abstract]   [Full Text] [Related]  

  • 9. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
    Sicsic J; Pelletier-Fleury N; Moumjid N
    Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast, prostate, and thyroid cancer screening tests and overdiagnosis.
    Jung M
    Curr Probl Cancer; 2017; 41(1):71-79. PubMed ID: 28104314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Do Women View Risk-Based Mammography Screening? A Qualitative Study.
    He X; Schifferdecker KE; Ozanne EM; Tosteson ANA; Woloshin S; Schwartz LM
    J Gen Intern Med; 2018 Nov; 33(11):1905-1912. PubMed ID: 30066118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial.
    Hersch J; McGeechan K; Barratt A; Jansen J; Irwig L; Jacklyn G; Houssami N; Dhillon H; McCaffery K
    BMJ Open; 2017 Oct; 7(10):e016246. PubMed ID: 28988168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.
    Hersch J; Barratt A; Jansen J; Houssami N; Irwig L; Jacklyn G; Dhillon H; Thornton H; McGeechan K; Howard K; McCaffery K
    BMJ Open; 2014 May; 4(5):e004990. PubMed ID: 24833692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT.
    Duffy S; Vulkan D; Cuckle H; Parmar D; Sheikh S; Smith R; Evans A; Blyuss O; Johns L; Ellis I; Sasieni P; Wale C; Myles J; Moss S
    Health Technol Assess; 2020 Oct; 24(55):1-24. PubMed ID: 33141657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Women's Awareness of the Benefits and Harms of Mammography Screening and Associations with Confusion, Ambivalence, and Information Seeking.
    Shi W; Nagler RH; Fowler EF; Gollust SE
    Health Commun; 2021 Mar; 36(3):303-314. PubMed ID: 31690128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of overdiagnosis in breast cancer screening using a non-homogeneous multi-state model: A simulation study.
    Wu WY; Nyström L; Jonsson H
    J Med Screen; 2018 Dec; 25(4):183-190. PubMed ID: 29153013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening mammography in older women: a review.
    Walter LC; Schonberg MA
    JAMA; 2014 Apr; 311(13):1336-47. PubMed ID: 24691609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decision-making about mammographic screening: pursuing informed choice.
    Hersch J; Jansen J; McCaffery K
    Climacteric; 2018 Jun; 21(3):209-213. PubMed ID: 29419315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.